Chief Financial Officer

Vice President, Clinical Research and Regulatory Affairs

Arcellx resumed with a Buy at Stifel

Arcellx assumed with a Neutral at Cantor Fitzgerald

Arcellx Insider Sold Shares Worth $1,709,723, According to a Recent SEC Filing

Arcellx's Chief Medical Officer Sells Shares

Medical Science Liaison

Arcellx is a public, clinical-stage biotechnology company focused on innovative immunotherapies for patients with cancer. The Medical Science Liaison will serve as a key scientific resource on cell therapy, engaging with healthcare professionals and thought leaders to support the company's medical strategies and clinical programs.

Medical Science Liaison (Southern California)

Chief People Officer

Senior Medical Science Liaison

Sign up with Google

Sign in with Google